Cell-based therapy reduced the RNA expression levels of inflammatory cytokines in the AD skin, suppressed the serum IgE levels, and decreased the proinflammatory cytokines like IL-1b, IL-4, IL-6, IL-10, and IL-13. This evidence concerns the gene IL6 and Alzheimer disease.